A 66-year-old woman developed systemic sclerosis (SSc) 
Introduction

Interferon alphacon-1 (consensus interferon) is used as a treatment for chronic hepatitis C. IFNαcon-1 is novel synthetic recombinant interferon that was developed by comparing the amino acid sequences of several natural IFNα subtypes and assigning the most frequently observed amino acid to each position to generate a consensus molecule. When used to treat high-titer genotype 1 HCV infection, IFNαcon-1 has been shown to induce normalization of liver function in 44% of patients and a sustained viral response (SVR) in 26% (1). However, IFNα (including
has multiple effects on the immune system and it may trigger the development of autoantibodies or even the onset or exacerbation of autoimmune diseases such as autoimmune thyroid disease, rheumatoid arthritis, systemic lupus erythematosus, and polymyositis (2) (3) (4) (5) Skin biopsy was performed at the extensor side forearm, and it showed atrophy of the epidermis with the dermis thickened (Fig. 2) . In the deep layer of the dermis, collagen fibers were increased, while blood vessels and skin appendages were decreased. Overall, the histopathological features of the skin were compatible with SSc. The plain chest X-ray film and chest computed tomography showed chronic pleurisy.
F i g u r e 2 . S k i n b i o p s y . T h e e p i d e r mi s i s a t r o p h i c , wh i l e t h e d e r mi s i s t h i c k e n e d . I n t h e d e e p l a y e r o f t h e d e r mi s c o l l a g e n t h e f i b e r s a r e i n c r e a s e d , wh i l e b l o o d v e s s e l s a n d s k i n a p p e n d a g e s s h o w a d e c r e a s e . ( He ma t o x y l i n a n d e o s i n s t a i n × 2 0 ) .
Based on these clinical, radiological, and histopathological findings, as well as proximal scleroderma, Raynaud's phenomenon, and ANA positivity, the diagnosis of SSc was established according to criteria defined by a Research Group of the Japanese Ministry of Health, Labour and Welfare in 1992 (6). The criteria of the American Rheumatism Association were also satisfied (7).
Treatment with tocopherol nicotinate gave symptomatic relief (Fig. 3) (2) (3) (4) (5) (11, 12) . It has also been reported that bleomycin, docetaxel, and other chemotherapy drugs can induce SSc (13, 14) . (17, 18) . In particular, IFNγ is of great relevance because it is the most potent stimulator of HLA class II antigen expression by endothelial cells, thus promoting endothelial cell-leukocyte adhesion (18) , but it is also a negative regulator of collagen production by fibroblasts (19) . Both IFNα and IFNγ have been shown to inhibit collagen synthesis or dermal and synovial fibroblast proliferation stimulated by transforming growth factor beta (TGFβ) in vitro (20, 21) , so these IFNs have been used to treat patients with SSc (22) (23) (24) (25) 
Discussion
IFN has multiple effects on the immune system. It is well known that IFN may trigger the appearance of autoantibodies, as well as the onset or exacerbation of various autoimmune phenomena. Although the incidence of overt autoimmune disease associated with IFN treatment is only about 1-4%, autoantibodies can be detected in 20-60% of the patients receiving IFN therapy (8-10). Autoimmune thyroid disease is the most frequent manifestation, but nearly all autoimmune diseases (including rheumatoid arthritis, SLE polymyositis) can occur
SSc is a multisystem disorder of unknown aetiology that is characterized by the deposition of excessive amounts of collagen in the skin and internal organs (15). Hallmarks of the disease are "leathery" skin and fibrosis of the affected organs. Activation of certain T lymphocyte subpopulations and fibroblasts plays a key role in the development of SSc (16). Studies of cytokines in SSc patients have shown a spontaneous increase of 'fibrogenic' cytokines, such as tumor necrosis factor-alpha (TNFα) and IL-1β, as well as impairment of mitogen-induced IFNγ production
